SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
10856101
Source:
http://linkedlifedata.com/resource/pubmed/id/10856101
Search
Subject
(
60
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008838
,
umls-concept:C0020823
,
umls-concept:C0030705
,
umls-concept:C0087111
,
umls-concept:C0144576
,
umls-concept:C0855197
pubmed:issue
12
pubmed:dateCreated
2000-7-18
pubmed:abstractText
To evaluate the dose, toxicity, and efficacy of paclitaxel in combination with ifosfamide and cisplatin as salvage therapy for patients with relapsed testicular germ cell tumors (GCTs).
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/CA 05826
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin
,
http://linkedlifedata.com/resource/pubmed/chemical/Granulocyte Colony-Stimulating...
,
http://linkedlifedata.com/resource/pubmed/chemical/Ifosfamide
,
http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel
,
http://linkedlifedata.com/resource/pubmed/chemical/Taxoids
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0732-183X
pubmed:author
pubmed-author:BacikJJ
,
pubmed-author:BainsMM
,
pubmed-author:BajorinDD
,
pubmed-author:BoslG JGJ
,
pubmed-author:MarianiTT
,
pubmed-author:MazumdarMM
,
pubmed-author:MotzerR JRJ
,
pubmed-author:SheinfeldJJ
pubmed:issnType
Print
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2413-8
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:10856101-Adult
,
pubmed-meshheading:10856101-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:10856101-Cisplatin
,
pubmed-meshheading:10856101-Drug Administration Schedule
,
pubmed-meshheading:10856101-Germinoma
,
pubmed-meshheading:10856101-Granulocyte Colony-Stimulating Factor
,
pubmed-meshheading:10856101-Humans
,
pubmed-meshheading:10856101-Ifosfamide
,
pubmed-meshheading:10856101-Male
,
pubmed-meshheading:10856101-Middle Aged
,
pubmed-meshheading:10856101-Neoplasm Recurrence, Local
,
pubmed-meshheading:10856101-Paclitaxel
,
pubmed-meshheading:10856101-Salvage Therapy
,
pubmed-meshheading:10856101-Taxoids
,
pubmed-meshheading:10856101-Testicular Neoplasms
,
pubmed-meshheading:10856101-Treatment Outcome
pubmed:year
2000
pubmed:articleTitle
Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer.
pubmed:affiliation
Department of Medicine, Joan and Sanford I Weill Medical College of Cornell University, New York, NY 10021, USA.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Research Support, U.S. Gov't, P.H.S.
,
Research Support, Non-U.S. Gov't
,
Clinical Trial, Phase II